Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in KYNB — Kyntra Bio, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to KYNB Full portfolio

Position in KYNB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record

Derivatives in KYNB

reported options exposure · as of Jun 30, 2026
CallValue
$674,970
CallShares
89,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in KYNB

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $674,970 89,400
2026-03-31 $606,132 89,400
2025-12-31 $413,538 47,100
2025-12-31 $2,065,934 235,300
2025-09-30 $2,882,425 235,300
2025-09-30 $576,975 47,100
2025-06-30 $294,150 55,500
2025-06-30 $1,449,020 273,400